1. Home
  2. FNWB vs HOWL Comparison

FNWB vs HOWL Comparison

Compare FNWB & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$9.96

Market Cap

87.9M

Sector

Finance

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$1.10

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
HOWL
Founded
1923
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.9M
64.5M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
FNWB
HOWL
Price
$9.96
$1.10
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$13.50
$7.00
AVG Volume (30 Days)
29.6K
490.6K
Earning Date
01-28-2026
11-04-2025
Dividend Yield
1.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$54,052,000.00
N/A
Revenue This Year
$31.86
N/A
Revenue Next Year
$10.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.47
N/A
52 Week Low
$6.05
$0.60
52 Week High
$12.10
$2.38

Technical Indicators

Market Signals
Indicator
FNWB
HOWL
Relative Strength Index (RSI) 64.85 52.22
Support Level $9.80 $0.96
Resistance Level $10.14 $1.03
Average True Range (ATR) 0.21 0.09
MACD -0.04 0.04
Stochastic Oscillator 46.15 96.55

Price Performance

Historical Comparison
FNWB
HOWL

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: